
    
      It is not yet known which protocols are a better treatment for glioblastoma or glioma.

      The ipilimumab extended-access program for patients who received previous chemotherapy and /
      or radiation therapy by protocol, before ((for non-operable cases) or after the operation.

      Monoclonal antibodies of CTLA-4, such as ipilimumab, may block tumor growth in different ways
      by targeting certain cells and activating the patient's immune system to fight the disease.
    
  